Despina Televantou

1.0k total citations
18 papers, 492 citations indexed

About

Despina Televantou is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Despina Televantou has authored 18 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Despina Televantou's work include Glioma Diagnosis and Treatment (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). Despina Televantou is often cited by papers focused on Glioma Diagnosis and Treatment (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). Despina Televantou collaborates with scholars based in Greece, United Kingdom and Australia. Despina Televantou's co-authors include George Fountzilas, Vassiliki Kotoula, Anastasia G Eleftheraki, Huw D. Thomas, Panagiotis Selviaridis, Despina Misailidou, Simon Bomken, Rachel E. Crossland, Vikki Rand and Chris M. Bacon and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Despina Televantou

16 papers receiving 489 citations

Peers

Countries citing papers authored by Despina Televantou

Since Specialization

Citations

This map shows the geographic impact of Despina Televantou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Despina Televantou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Despina Televantou more than expected).

Fields of papers citing papers by Despina Televantou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Despina Televantou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Despina Televantou. The network helps show where Despina Televantou may publish in the future.

Co-authorship network of co-authors of Despina Televantou

This figure shows the co-authorship network connecting the top 25 collaborators of Despina Televantou. A scholar is included among the top collaborators of Despina Televantou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Despina Televantou. Despina Televantou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma 2021 ·Leukemia ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Rachel E. Crossland, Sarah Wilkinson, Amir Enshaei, (unknown), Fiona Harding, Mary Taj, Katrina Wood, Despina Televantou, Suzanne D. Turner, G.A. Amos Burke, Christine J. Harrison, Simon Bomken, Chris M. Bacon, Vikki Rand	23
2	Immunosuppression-induced clonal T-cell lymphoproliferative disease causing severe diarrhoea mimicking coeliac disease following renal transplantation: a case report 2020 ·BMC Nephrology ·(unknown), Ally Speight, Despina Televantou, Stephanie Needham, Neil Sheerin	0
3	Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment 2019 ·Cancer Genomics & Proteomics ·Helena Linardou, (unknown), G. Kouvatseas, Giannis Mountzios, Vasilios Karavasilis, E. Samantas, Anna Kalogera‐Fountzila, Despina Televantou, Kyriaki Papadopoulou, (unknown), (unknown), Thomas Zaramboukas, Ioannis Efstratiou, Sofia Lampaki, (unknown), (unknown), Konstantinos N. Syrigos, P. Kosmidis, Dimitrios Pectasides, George Fountzilas	11
4	Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma 2017 ·Haematologica ·(unknown), (unknown), Helen J. Blair, (unknown), Huw D. Thomas, Nicole Phillips, Sirintra Nakjang, Satomi Miwa, Rachel E. Crossland, Vikki Rand, Despina Televantou, Anna Long, Hector C. Keun, Chris M. Bacon, Simon Bomken, Susan E. Critchlow, Stephen R. Wedge	119
5	Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cancer 2016 ·European Journal of Cancer ·Nicola Cresti, Joanne Lee, Emma Rourke, Despina Televantou, David Jamieson, Mark Verrill, Alan V. Boddy	13
6	Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma 2016 ·British Journal of Cancer ·(unknown), Beate Haugk, Laura Ogle, Gary Beale, Anna Long, Alastair D. Burt, Dina Tiniakos, Despina Televantou, Fareeda Y. Coxon, David R. Newell, Richard Charnley, Helen L. Reeves	14
7	Calpain‐1 is associated with adverse relapse free survival in breast cancer: a confirmatory study 2015 ·Histopathology ·Xuan Pu, Sarah J. Storr, (unknown), Stephen Chan, Paul M. Moseley, Despina Televantou, Nicola Cresti, Alan V. Boddy, Ian O. Ellis, Stewart G. Martin	10
8	DNA-PK—A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival 2014 ·Clinical Cancer Research ·Liam Cornell, Joanne M. Munck, Clara Alsinet, Augusto Villanueva, Laura Ogle, Catherine E. Willoughby, Despina Televantou, Huw D. Thomas, Jennifer Jackson, Alastair D. Burt, David R. Newell, John Rose, Derek Manas, Geoffrey I. Shapiro, Nicola J. Curtin, Helen L. Reeves	69
9	Prognostic significance of the Wnt pathway in squamous cell laryngeal cancer 2014 ·Oral Oncology ·Amanda Psyrri, Vassiliki Kotoula, Elena Fountzilas, Zoi Alexopoulou, Mattheos Bobos, Despina Televantou, Georgia Karayannopoulou, Dimitrios Krikelis, Konstantinos Markou, (unknown), Nikolaos Angouridakis, Konstantine T. Kalogeras, Angelos Nikolaou, George Fountzilas	23
10	Evaluation of current prognostic and predictive markers in breast cancer: a validation study of tissue microarrays. 2013 ·PubMed ·Anna Batistatou, Despina Televantou, Mattheos Bobos, Anastasia G Eleftheraki, Evangelos Kouvaras, Sofia Chrisafi, George Κ. Koukoulis, Vassiliki Malamou‐Mitsi, George Fountzilas	14
11	A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas 2013 ·Journal of Neurology ·Vasilios Karavasilis, Vassiliki Kotoula, George Pentheroudakis, Despina Televantou, (unknown), Sofia Chrisafi, Mattheos Bobos, George Fountzilas	17
12	The Prognostic Role of Ephrin A2 and Endothelial Growth Factor Receptor Pathway Mediators in Patients With Advanced Colorectal Cancer Treated With Cetuximab 2013 ·Clinical Colorectal Cancer ·Alexios S Strimpakos, George Pentheroudakis, Vassiliki Kotoula, Wendy De Roock, George Kouvatseas, Pavlos Papakostas, Thomas Makatsoris, Demetris Papamichael, (unknown), Joseph Sgouros, Adamantia Zizi-Sermpetzoglou, A. Kominea, Despina Televantou, Evangelia Razis, Eleni Galani, Dimitrios Pectasides, Sabine Tejpar, Konstantinos Syrigos, George Fountzilas	25
13	Volumetric and MGMT parameters in glioblastoma patients: Survival analysis 2012 ·BMC Cancer ·(unknown), Vassiliki Kotoula, (unknown), Despina Televantou, Anastasia G Eleftheraki, (unknown), Despina Misailidou, Panagiotis Selviaridis, George Fountzilas	68
14	Improved Outcome of High-Risk Early HER2 Positive Breast Cancer With High CXCL13-CXCR5 Messenger RNA Expression 2012 ·Clinical Breast Cancer ·Evangelia Razis, Konstantine T. Kalogeras, Vassiliki Kotoula, Anastasia G Eleftheraki, Nikitas Nikitas, Ralf Kronenwett, Eleni Timotheadou, Christos Christodoulou, Dimitrios Pectasides, Helen Gogas, Ralph M. Wirtz, Thomas Makatsoris, Dimitrios Bafaloukos, Gerasimos Aravantinos, Despina Televantou, Nicholas Pavlidis, George Fountzilas	46
15	Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS) 2012 ·BMC Cancer ·Vassiliki Kotoula, Dimitrios Krikelis, Vasilios Karavasilis, Triantafyllia Κoletsa, Anastasia G Eleftheraki, Despina Televantou, Christos Christodoulou, (unknown), Ippokratis Korantzis, Dimitrios Pectasides, Konstantinos N. Syrigos, P. Kosmidis, George Fountzilas	24
16	DARPP32, STAT5 and STAT3 mRNA Expression Ratios in Glioblastomas are Associated with Patient Outcome 2012 ·Pathology & Oncology Research ·Despina Televantou, George Karkavelas, Prodromos Hytiroglou, Sofia Lampaki, (unknown), Panagiotis Selviaridis, Konstantinos S. Polyzoidis, George Fountzilas, Vassiliki Kotoula	9
17	STAT-Related Profiles Are Associated with Patient Response to Targeted Treatments in Locally Advanced SCCHN 2011 ·Translational Oncology ·Vassiliki Kotoula, (unknown), Despina Televantou, Anna Kalogera‐Fountzila, (unknown), Konstantinos Markou, Despina Misailidou, Konstantinos N. Syrigos, George Fountzilas	7
18	PD05-02: Effect of HER2/Topoisomerase II alpha (TOP2A) Gene Status or Protein Expression and Chromosome 17 (CEP17) Polysomy on the Outcome of Breast Cancer Patients Treated with Anthracycline-Containing Dose-Dense Sequential Adjuvant Chemotherapy with or without Paclitaxel – A Pooled Analysis of Two Hellenic Cooperative Oncology Group (HeCOG) Phase III Trials. 2011 ·Cancer Research ·Urania Dafni, Mattheos Bobos, Eleftheria Tsolaki, Anna Batistatou, (unknown), Despina Televantou, Helen Gogas, Helena Linardou, Dimitrios Pectasides, (unknown), Eleni Galani, Αngelos Koutras, (unknown), George Fountzilas	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact